Skip to main content

Animations

MJFF Publications

4811 - 4820 of 8818 Results
Title
Year
  • Year
  • 2023
  • 2021
  • 2021
  • 2022
  • 2021
  • 2022
  • 2021
  • 2022
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: A beginner’s guide into curated analyses of open access datasets for biomarker discovery in neurodegeneration
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41597-023-02338-1
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Systematic Review on Parkinson’s Disease Medications, Emphasizing on Three Recently Approved Drugs to Control Parkinson’s Symptoms
    Journal Name: International Journal of Environmental Research and Public Health
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijerph19010364
    Citation Count: 67
  • Summary Details
    OPEN
    Title: Longitudinal clustering analysis and prediction of Parkinson’s disease progression using radiomics and hybrid machine learning
    Journal Name: Quantitative Imaging in Medicine and Surgery
    Publisher: AME Publishing Company
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.21037/qims-21-425
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Cellular localization of p-tau217 in brain and its association with p-tau217 plasma levels
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-021-01307-2
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Dysregulation of mitochondrial and proteolysosomal genes in Parkinson’s disease myeloid cells
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-021-00110-x
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Functional MAOB Gene Intron 13 Polymorphism Predicts Dyskinesia in Parkinson’s Disease
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2022/5597503
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000013121
    Citation Count: 87
  • Summary Details
    OPEN
    Title: Mapping brain structural differences and neuroreceptor correlates in Parkinson’s disease visual hallucinations
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-022-28087-0
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Genetic risk, adherence to a healthy lifestyle, and cognitive decline in African Americans and European Americans
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.12435
    Citation Count: 31
  • Summary Details
    OPEN
    Title: PhosPiR: an automated phosphoproteomic pipeline in R
    Journal Name: Briefings in Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/bib/bbab510
    Citation Count: 9
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.